Results 31 to 40 of about 41,659 (245)

Electronic medical record implementation in tertiary care: factors influencing adoption of an electronic medical record in a cancer centre

BMC Health Services Research, 2021
Background Electronic Medical Records (EMRs) are one of a range of digital health solutions that are key enablers of the data revolution transforming the health sector.
Anna Janssen, Candice Donnelly, Elisabeth Elder, Nirmala Pathmanathan, Tim Shaw   +4 more
doaj   +1 more source

Early Body Mass Index z‐Score Change and Resolution of Severe Malnutrition in Children With Sickle Cell Anemia in a Low‐Income Setting: A Prospective Single‐Arm Extension Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with sickle cell anemia (SCA) in low‐income settings are at risk of severe malnutrition, but optimal nutritional management has not been established. We evaluated an intensified ready‐to‐use therapeutic food (RUTF) regimen in children with persistent severe malnutrition after initial treatment and assessed whether early ...
Safiya Gambo, Shehu Umar Abdullahi, Hassan Adam Murtala, Halima Kabir, Khadija A. Shamsu, Sari A. Acra, Virginia A. Stallings, Mark Rodeghier, Michael R. DeBaun, Lauren J. Klein   +9 more
wiley   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Planckpre-launch status: Design and description of the Low Frequency Instrument [PDF]

Astronomy and Astrophysics, 2010
In this paper we present the Low Frequency Instrument (LFI), designed and developed as part of the Planck space mission, the ESA program dedicated to precision imaging of the cosmic microwave background (CMB). Planck-LFI will observe the full sky in intensity and polarisation in three frequency bands centred at 30, 44 and 70 GHz, while higher ...
M Bersanelli, N Mandolesi, R C Butler, A Mennella, F Villa, B Aja, E Artal, E Artina, C Baccigalupi, M Balasini, G Baldan, A Banday, P Bastia, P Battaglia, T Bernardino, E Blackhurst, L Boschini, C Burigana, G Cafagna, B Cappellini, F Cavaliere, F Colombo, G Crone, F Cuttaia, O D Arcangelo, L Danese, R D Davies, R J Davis, L De Angelis, G C De Gasperis, L De La Fuente, A De Rosa, G De Zotti, M C Falvella, F Ferrari, R Ferretti, L Figini, S Fogliani, C Franceschet, E Franceschi, T Gaier, S Garavaglia, F Gomez, K Gorski, A Gregorio, P Guzzi, J M Herreros, S R Hildebrandt, R Hoyland, N Hughes, M Janssen, P Jukkala, D Kettle, V H Kilpiä, M Laaninen, P M Lapolla, C R Lawrence, D Lawson, J P Leahy, R Leonardi, P Leutenegger, S Levin, P B Lilje, S R Lowe, P M Lubin, DMaino, M Malaspina, M Maris, J MartiCanales, E MartinezGonzalez, A Mediavilla, P Meinhold, M Miccolis, G Morgante, P Natoli, R Nesti, L Pagan, C Paine, B Partridge, J P Pascual, F Pasian, D Pearson, M Pecora, F Perrotta, P Platania, M Pospieszalski, T Poutanen, M Prina, R Rebolo, N Roddis, J A RubiñoMartin, M J Salmon, M Sandri, M Seiffert, R Silvestri, A Simonetto, P Sjoman, G F Smoot, C Sozzi, L Stringhetti, E Taddei, J Tauber, L Terenzi, M Tomasi, J Tuovinen, L Valenziano, J Varis, N Vittorio, L A Wade, A Wilkinson, FWinder, A Zacchei, A Zonca   +112 more
openaire   +15 more sources

Pre-Launch Day-Night Band Radiometric Performance of JPSS-3 and -4 VIIRS

Remote Sensing
Following the success of Visible Infrared Imaging Radiometer Suite (VIIRS) instruments currently operating onboard the Suomi-NPP, NOAA-20, and NOAA-21 spacecraft, preparations are underway for the final two VIIRS instruments for the Joint Polar Satellite
Daniel Link, Thomas Schwarting, Amit Angal, Xiaoxiong Xiong   +3 more
doaj   +1 more source

Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades

BMC Health Services Research, 2022
Background The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades.
Melanie Büssgen, Tom Stargardt
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

HIRDLS Pre-Launch Presentations

, 2000
Previously curated at: http://cedadocs.ceda.ac.uk/1137/ Event type: conference. The publish date on this item was its original completed date. This item was not refereed before the publication Main files in this record: HIRDLS_Pre-Launch_Presentation_1.pdf HIRDLS_Pre-Launch_Presentation_2.pdf HIRDLS_Pre-Launch_Presentation_3.pdf HIRDLS_Pre ...
Gille, John, Barnett, John
openaire   +2 more sources

Dabigatran – an exemplar case history demonstrating the need for comprehensive models to optimise the use of new drugs

Frontiers in Pharmacology, 2014
Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/ or budget concerns.
Brian eGodman, Brian eGodman, Rickard eMalmstrom, Eduardo eDiogene, Sisira eJayathissa, Stuart eMcTaggart, Thomas eCars, Thomas eCars, Christoph eBaumgärtel, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Kristina eGaruoliene, Iñaki eGutiérrez-Ibarluzea, Krystyna eHviding, Harald eHerholz, Roberta eJoppi, Marija eKalaba, Ott eLaius, Kamila eMalinowska, Kamila eMalinowska, Hanne B Pedersen, Vanda eMarkovic-Pekovic, Vanda eMarkovic-Pekovic, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Magdelena eWladysiuk, Menno eVan Woerkom, Corinne eZara, Lars L Gustafsson   +37 more
doaj   +1 more source